Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-028582
Filing Date
2017-05-19
Accepted
2017-05-19 12:54:42
Documents
83
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466193_10q.htm 10-Q 473133
2 EXHIBIT 3.1 v466193_ex3-1.htm EX-3.1 14155
3 EXHIBIT 31.1 v466193_ex31-1.htm EX-31.1 11590
4 EXHIBIT 32.1 v466193_ex32-1.htm EX-32.1 4397
  Complete submission text file 0001144204-17-028582.txt   6856792

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prgb-20170331.xml EX-101.INS 1560802
6 XBRL TAXONOMY EXTENSION SCHEMA prgb-20170331.xsd EX-101.SCH 82293
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prgb-20170331_cal.xml EX-101.CAL 47296
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgb-20170331_def.xml EX-101.DEF 514561
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgb-20170331_lab.xml EX-101.LAB 527825
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgb-20170331_pre.xml EX-101.PRE 554595
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 17857144
SIC: 2834 Pharmaceutical Preparations